Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy

Cancer Letters

Volumn 252, Issue 1, 2007, Pages 1-8

  López Lázaro, Miguel ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Antioxidant; Apoptosis; Carcinogenesis; Hypoxia inducible factor; Prooxidant; Reactive oxygen species

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1;

ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; CHEMOTHERAPY; HUMAN; METASTASIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 34248396033     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.10.029     Document Type: Review

References (104)

1. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
2. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18 (1995) 775-794
3. Balaban R.S., Nemoto S., and Finkel T. Mitochondria, oxidants, and aging. Cell 120 (2005) 483-495
4. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3 (2002) 1129-1134
5. Lopez-Lazaro M. HIF-1: Hypoxia-inducible factor or Dysoxia-inducible factor?. FASEB J. 20 (2006) 828-832
6. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 239-267
7. Church S.L., Grant J.W., Ridnour L.A., Oberley L.W., Swanson P.E., Meltzer P.S., and Trent J.M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA 90 (1993) 3113-3117
8. Safford S.E., Oberley T.D., Urano M., and St Clair D.K. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. 54 (1994) 4261-4265
9. Yan T., Oberley L.W., Zhong W., and St Clair D.K. Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res. 56 (1996) 2864-2871
10. Zhang Y., Zhao W., Zhang H.J., Domann F.E., and Oberley L.W. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res. 62 (2002) 1205-1212
11. Li J.J., Oberley L.W., Fan M., and Colburn N.H. Inhibition of AP-1 and NF-kappaB by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J. 12 (1998) 1713-1723
12. Zhang H.J., Yan T., Oberley T.D., and Oberley L.W. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res. 59 (1999) 6276-6283
13. 2. Free Radic. Biol. Med. 29 (2000) 801-813
14. Li S., Yan T., Yang J.Q., Oberley T.D., and Oberley L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 60 (2000) 3927-3939
15. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
16. Folkman J., Hahnfeldt P., and Hlatky L. Cancer: looking outside the genome. Nat. Rev. Mol. Cell Biol. 1 (2000) 76-79
17. Soto A.M., and Sonnenschein C. The somatic mutation theory of cancer: growing problems with the paradigm?. Bioessays 26 (2004) 1097-1107
18. Gibbs W.W. Untangling the roots of cancer. Sci. Am. 289 (2003) 56-65
19. Jaffe L.F. Epigenetic theories of cancer initiation. Adv. Cancer Res. 90 (2003) 209-230
20. Prehn R.T. Cancers beget mutations versus mutations beget cancers. Cancer Res. 54 (1994) 5296-5300
21. Stern R.G., Milestone B.N., and Gatenby R.A. Carcinogenesis and the plasma membrane. Med. Hypotheses 52 (1999) 367-372
22. Duesberg P. Does aneuploidy or mutation start cancer?. Science 307 (2005) 41
23. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
24. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
25. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347 (2002) 1593-1603
26. Park S., You X., and Imlay J.A. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx- mutants of Escherichia coli. Proc. Natl. Acad. Sci. USA 102 (2005) 9317-9322
27. Hunt C.R., Sim J.E., Sullivan S.J., Featherstone T., Golden W., Kapp-Herr C., et al. Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress. Cancer Res. 58 (1998) 3986-3992
28. Jackson A.L., and Loeb L.A. Microsatellite instability induced by hydrogen peroxide in Escherichia coli. Mutat. Res. 447 (2000) 187-198
29. Pericone C.D., Bae D., Shchepetov M., McCool T., and Weiser J.N. Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J. Bacteriol. 184 (2002) 4392-4399
30. Henle E.S., and Linn S. Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide. J. Biol. Chem. 272 (1997) 19095-19098
31. Imlay J.A., and Linn S. DNA damage and oxygen radical toxicity. Science 240 (1988) 1302-1309
32. Zanetti M., Katusic Z.S., and O'Brien T. Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2620-H2626
33. Polytarchou C., Hatziapostolou M., and Papadimitriou E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 280 (2005) 40428-40435
34. Brown M.R., Miller Jr. F.J., Li W.G., Ellingson A.N., Mozena J.D., Chatterjee P., et al. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ. Res. 85 (1999) 524-533
35. del Bello B., Paolicchi A., Comporti M., Pompella A., and Maellaro E. Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB J. 13 (1999) 69-79
36. Qian Y., Luo J., Leonard S.S., Harris G.K., Millecchia L., Flynn D.C., and Shi X. Hydrogen peroxide formation and actin filament reorganization by Cdc42 are essential for ethanol-induced in vitro angiogenesis. J. Biol. Chem. 278 (2003) 16189-16197
37. Arbiser J.L., Petros J., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., et al. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA 99 (2002) 715-720
38. Nelson K.K., Ranganathan A.C., Mansouri J., Rodriguez A.M., Providence K.M., Rutter J.L., et al. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. 9 (2003) 424-432
39. Nishikawa M., Tamada A., Hyoudou K., Umeyama Y., Takahashi Y., Kobayashi Y., et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin. Exp. Metastasis 21 (2004) 213-221
40. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
41. Semenza G.L. Development of novel therapeutic strategies that target HIF-1. Expert. Opin. Ther. Targets 10 (2006) 267-280
42. Nishi H., Nakada T., Kyo S., Inoue M., Shay J.W., and Isaka K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol. Cell Biol. 24 (2004) 6076-6083
43. Yatabe N., Kyo S., Maida Y., Nishi H., Nakamura M., Kanaya T., et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 23 (2004) 3708-3715
44. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59 (1999) 5830-5835
45. 2 sensing. J. Biol. Chem. 275 (2000) 25130-25138
46. Haddad J.J., and Land S.C. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505 (2001) 269-274
47. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1 (2005) 409-414
48. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1 (2005) 401-408
49. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., and Simon M.C. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 1 (2005) 393-399
50. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991) 794-798
51. Zieba M., Suwalski M., Kwiatkowska S., Piasecka G., Grzelewska-Rzymowska I., Stolarek R., and Nowak D. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir. Med. 94 (2000) 800-805
52. Lim S.D., Sun C., Lambeth J.D., Marshall F., Amin M., Chung L., et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62 (2005) 200-207
53. Okamoto M., Kawai K., Reznikoff C.A., and Oyasu R. Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide. Cancer Res. 56 (1996) 4649-4653
54. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
55. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., et al. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA 98 (2001) 5550-5555
56. 2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer 70 (1997) 716-721
57. Policastro L., Molinari B., Larcher F., Blanco P., Podhajcer O.L., Costa C.S., et al. Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol. Carcinog. 39 (2004) 103-113
58. Yang J.Q., Buettner G.R., Domann F.E., Li Q., Engelhardt J.F., Weydert C.D., and Oberley L.W. v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species. Mol. Carcinog. 33 (2002) 206-218
59. Ahmad K.A., Iskandar K.B., Hirpara J.L., Clement M.V., and Pervaiz S. Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res. 64 (2004) 7867-7878
60. Hirpara J.L., Clement M.V., and Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J. Biol. Chem. 276 (2001) 514-521
61. Clement M.V., Hirpara J.L., and Pervaiz S. Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria. Cell Death Differ. 10 (2003) 1273-1285
62. Alexandre J., Nicco C., Chereau C., Laurent A., Weill B., Goldwasser F., and Batteux F. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J. Natl. Cancer Inst. 98 (2006) 236-244
63. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., and Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94 (1999) 2102-2111
64. Mizutani H., Tada-Oikawa S., Hiraku Y., Kojima M., and Kawanishi S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 76 (2005) 1439-1453
65. Wagner B.A., Evig C.B., Reszka K.J., Buettner G.R., and Burns C.P. Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells. Arch. Biochem. Biophys. 440 (2005) 181-190
66. Alexandre J., Batteux F., Nicco C., Chereau C., Laurent A., Guillevin L., et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int. J. Cancer 119 (2006) 41-48
67. Sancho P., Troyano A., Fernandez C., De Blas E., and Aller P. Differential effects of catalase on apoptosis induction in human promonocytic cells. Relationships with heat-shock protein expression. Mol. Pharmacol. 63 (2003) 581-589
68. Kajiwara K., Ikeda K., Kuroi R., Hashimoto R., Tokumaru S., and Kojo S. Hydrogen peroxide and hydroxyl radical involvement in the activation of caspase-3 in chemically induced apoptosis of HL-60 cells. Cell Mol. Life Sci. 58 (2001) 485-491
69. Ikeda K., Kajiwara K., Tanabe E., Tokumaru S., Kishida E., Masuzawa Y., and Kojo S. Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. Biochem. Pharmacol. 57 (1999) 1361-1365
70. Simizu S., Takada M., Umezawa K., and Imoto M. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J. Biol. Chem. 273 (1998) 26900-26907
71. Gorman A., McGowan A., and Cotter T.G. Role of peroxide and superoxide anion during tumour cell apoptosis. FEBS Lett. 404 (1997) 27-33
72. Lee Y.S., Kang Y.S., Lee S.H., and Kim J.A. Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ. 7 (2000) 925-932
73. Maeda H., Hori S., Ohizumi H., Segawa T., Kakehi Y., Ogawa O., and Kakizuka A. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ. 11 (2004) 737-746
74. Chen Q., Espey M.G., Krishna M.C., Mitchell J.B., Corpe C.P., Buettner G.R., et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA 102 (2005) 13604-13609
75. Djavaheri-Mergny M., Wietzerbin J., and Besancon F. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 22 (2003) 2558-2567
76. Evens A.M., Lecane P., Magda D., Prachand S., Singhal S., Nelson J., Miller R.A., et al. Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells. Blood 105 (2005) 1265-1273
77. Nicco C., Laurent A., Chereau C., Weill B., and Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed. Pharmacother. 59 (2005) 169-174
78. Holman R.A. A method of destroying a malignant rat tumour in vivo. Nature 179 (1957) 1033
79. Jeffree G.M. Hydrogen peroxide and cancer. Nature 182 (1958) 892
80. Nathan C.F., and Cohn Z.A. Antitumor effects of hydrogen peroxide in vivo. J. Exp. Med. 154 (1981) 1539-1553
81. Questionable methods of cancer management: hydrogen peroxide and other 'hyperoxygenation' therapies, CA Cancer J. Clin. 43 (1993) 47-56.
82. Padayatty S.J., Riordan H.D., Hewitt S.M., Katz A., Hoffer L.J., and Levine M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174 (2006) 937-942
83. Poh T.W., and Pervaiz S. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Cancer Res. 65 (2005) 6264-6274
84. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
85. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
86. Sporn M.B., and Suh N. Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer 2 (2002) 537-543
87. Sporn M.B., and Liby K.T. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol. 2 (2005) 518-525
88. Kawanishi S., Oikawa S., and Murata M. Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox Signal 7 (2005) 1728-1739
89. Zhang P., and Omaye S.T. Antioxidant and prooxidant roles for beta-carotene, alpha-tocopherol and ascorbic acid in human lung cells. Toxicol. In Vitro 15 (2001) 13-24
90. Palozza P., Serini S., Di Nicuolo F., Piccioni E., and Calviello G. Prooxidant effects of beta-carotene in cultured cells. Mol. Aspects Med. 24 (2003) 353-362
91. Yoshino M., Haneda M., Naruse M., Htay H.H., Tsubouchi R., Qiao S.L., et al. Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2′-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol. In Vitro 18 (2004) 783-789
92. Yeh C.T., and Yen G.C. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26 (2005) 2138-2148
93. D'Incalci M., Steward W.P., and Gescher A.J. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol. 6 (2005) 899-904
94. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223 (2005) 181-190
95. Ito K., Nakazato T., Yamato K., Miyakawa Y., Yamada T., Hozumi N., et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 64 (2004) 1071-1078
96. Lee K.W., Lee H.J., Surh Y.J., and Lee C.Y. vitamin C and cancer chemoprevention: reappraisal. Am. J. Clin. Nutr. 78 (2003) 1074-1078
97. Lee K.W., Lee H.J., Kang K.S., and Lee C.Y. Preventive effects of vitamin C on carcinogenesis. Lancet 359 (2002) 172
98. Lee S.H., Oe T., and Blair I.A. vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292 (2001) 2083-2086
99. Byers T. What can randomized controlled trials tell us about nutrition and cancer prevention?. CA Cancer J. Clin. 49 (1999) 353-361
100. Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Meyskens Jr. F.L., Omenn G.S., et al. The beta-carotene and retinol efficacy trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J. Natl. Cancer Inst. 96 (2004) 1743-1750
101. Moyad M.A. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?. Urology 59 (2002) 9-19
102. Tafazoli S., Wright J.S., and O'Brien P.J. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem. Res. Toxicol. 18 (2005) 1567-1574
103. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 (2005) 37-46
104. van Zandwijk N., Dalesio O., Pastorino U., de Vries N., and van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J. Natl. Cancer Inst. 92 (2000) 977-986